Research

Adherence

GLP-1RAs may pose theoretical risks for individuals with restrictive eating disorders (e.g., Anorexia Nervosa) or high perfectionism, as appetite suppression can mask or reinforce rigid control and compensatory behaviors.

If you have a history of restrictive eating disorders or high perfectionism, GLP-1RAs require careful monitoring. The medication's ability to suppress appetite might mask or worsen restrictive behaviors, so prescribers should screen for these risks and watch for red flags like rapid weight loss or dizziness.

ModerateQualifiesMEDIUM confidence
Theoretical risks include restrictive behaviours being “masked” as medication adjustments (e.g., “dose working”) or compulsive reliance on pharmacological appetite suppression as a form of control
Isabel Krug et al. · Nutrients · 2025

Why this rating

Based on theoretical concerns and case reports; clinical evidence linking GLP-1RA use to the onset of AN is lacking.

Source

Beyond Weight Loss: GLP-1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes

Isabel Krug et al. · Nutrients · 2025

DOI 10.3390/nu17233735

narrative_reviewCited 3×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →